All Analysis articles
-
NewsAfter Stonegate: Unpicking Covid-19 BI aggregation potential
Why reinsurers should look to recent Covid-related judgments on the direct side in an effort to resolve uncertainty
-
FeaturesBriefing: Reinsurers still facing ‘big issue’ over BI (despite clarity for direct market)
A lack of visibility around aggregation arbitration is preventing reinsurers from dealing with COVID-related BI claims
-
NewsCyber: Hitting pause
At below $10 billion, why has the cyber re/insurance market failed to live up to its potential?
-
NewsUkraine: A ‘Matrix moment’ for climate change
The choices governments make in response to the Ukraine conflict might either accelerate or delay the global transition to net-zero emissions
-
NewsBriefing: Cracking the difficult US market for insurance
HomeServe is showing the difficult US market can be cracked. Other large UK insurance firms have struggled to make an impact though. Why is this?
-
NewsPace of technology innovation must be maintained
Insurance Times’ Tech and Innovation Awards showcased the great variety of digital solutions supporting the insurance sector
-
AnalysisBriefing: Why can’t insurers innovate like MGAs?
Conversations at BrokerFest 2021 indicated that MGAs have the edge on insurers when it comes to innovation
-
NewsBriefing: ‘Radical fresh thinking’ is required to tackle ‘connected’ risks and protection gaps
The Covid-19 pandemic has shone a - sometimes uncomfortable – spotlight on the insurance industry.
-
NewsBriefing: MGAs shine in broker survey…but a big concern remains
MGAs shine in survey, but brokers do have concerns
-
NewsBriefing: Will ADS safety rating put brakes on government’s automated driving push?
Industry commentators still have questions around the safety of technology such as ALKS, however the UK government is eager to have automated driving on Britain’s roads this year
-
NewsBriefing: Addressing emerging geopolitical risks is ‘major growth opportunity for insurers’
New Lloyd’s report calls for innovation around insurance for geopolitical risks as it identifies 10 ‘paradigm shift’ factors that could affect whether current cover is still fit for purpose
-
NewsBriefing: Pandemic predators - private equity dominance sparks concerns
Private equity is seen by some as predators of the pandemic, buying UK firms cheaply. Is it time for reform?
-
NewsBriefing: London market is still wrestling with its future as Freedom Day arrives
London market brokers query hybrid working models, while syndicates ponder whether Lloyd’s blueprint investment will pay off
-
NewsBriefing: Covid costs now hitting reinsurance bottom line
Covid-19, Solvency II and ESG factors will all be influencing global multiline insurers’ balance sheets, says S&P Global Ratings
-
NewsBriefing: What five SME products could come under the FCA’s fair value microscope?
The first deadline surrounding the FCA’s general insurance pricing reform is approaching fast - insurers and brokers must consider the implications on SME products if they haven’t done so already
-
NewsBriefing: Aon-WTW merger still hitting snags amid broader consolidation landscape
Aon still has its work cut out for it if it wants to complete its purchase of Willis Towers Watson and mitigate market competition worries – however, will competition concerns increase across the piece as a result of the recent consolidation uptick?
-
NewsBriefing: Solvency II and GDPR face big shake up amid Tory post-Brexit war cry
MP Iain Duncan Smith leads the charge on radical post-Brexit insurance plans
-
NewsBriefing: Fair value ‘fault line’ underpins FCA’s GI pricing proposals
The FCA may have ‘unleashed the concept’ around fair value, but now firms have to interpret this and embed it within their business practices, which isn’t an overnight job
-
NewsBriefing: Time is running out for summer festivals seeking Covid inclusive event cancellation cover
A new report by the Public Accounts Committee recognises that festivals are facing a ‘survival threat’ without adequate insurance for Covid-linked event cancellation
-
NewsBriefing: What exactly is Aviva’s activist investor Cevian up to?
An activist investor is stepping up pressure. But does it have anything new to offer?
